124 related articles for article (PubMed ID: 20116225)
1. Limitations in doxorubicin production from Streptomyces peucetius.
Malla S; Niraula NP; Singh B; Liou K; Sohng JK
Microbiol Res; 2010 Jul; 165(5):427-35. PubMed ID: 20116225
[TBL] [Abstract][Full Text] [Related]
2. Improvement in doxorubicin productivity by overexpression of regulatory genes in Streptomyces peucetius.
Malla S; Niraula NP; Liou K; Sohng JK
Res Microbiol; 2010 Mar; 161(2):109-17. PubMed ID: 20045726
[TBL] [Abstract][Full Text] [Related]
3. Precursor for biosynthesis of sugar moiety of doxorubicin depends on rhamnose biosynthetic pathway in Streptomyces peucetius ATCC 27952.
Singh B; Lee CB; Sohng JK
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1565-74. PubMed ID: 19777229
[TBL] [Abstract][Full Text] [Related]
4. Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.
Niraula NP; Kim SH; Sohng JK; Kim ES
Appl Microbiol Biotechnol; 2010 Jul; 87(4):1187-94. PubMed ID: 20508927
[TBL] [Abstract][Full Text] [Related]
5. Isolation and genetic manipulation of the antibiotic down-regulatory gene, wblA ortholog for doxorubicin-producing Streptomyces strain improvement.
Noh JH; Kim SH; Lee HN; Lee SY; Kim ES
Appl Microbiol Biotechnol; 2010 Apr; 86(4):1145-53. PubMed ID: 20020285
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.
Lomovskaya N; Otten SL; Doi-Katayama Y; Fonstein L; Liu XC; Takatsu T; Inventi-Solari A; Filippini S; Torti F; Colombo AL; Hutchinson CR
J Bacteriol; 1999 Jan; 181(1):305-18. PubMed ID: 9864344
[TBL] [Abstract][Full Text] [Related]
7. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.
Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR
Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius.
Malla S; Niraula NP; Liou K; Sohng JK
J Biosci Bioeng; 2009 Aug; 108(2):92-8. PubMed ID: 19619853
[TBL] [Abstract][Full Text] [Related]
9. Proteomic approach to enhance doxorubicin production in panK-integrated Streptomyces peucetius ATCC 27952.
Song E; Malla S; Yang YH; Lee K; Kim EJ; Lee HC; Sohng JK; Oh MK; Kim BG
J Ind Microbiol Biotechnol; 2011 Sep; 38(9):1245-53. PubMed ID: 21308395
[TBL] [Abstract][Full Text] [Related]
10. Feedback regulation of doxorubicin biosynthesis in Streptomyces peucetius.
Jiang H; Hutchinson CR
Res Microbiol; 2006 Sep; 157(7):666-74. PubMed ID: 16545946
[TBL] [Abstract][Full Text] [Related]
11. Enhanced doxorubicin production by Streptomyces peucetius using a combination of classical strain mutation and medium optimization.
Wang X; Tian X; Wu Y; Shen X; Yang S; Chen S
Prep Biochem Biotechnol; 2018; 48(6):514-521. PubMed ID: 29939834
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of mutants of Streptomyces peucetius subsp. caesius ATCC 27952 resistant to anthracycline antibiotics].
Dubyts'ka LP; Fedorenko VO
Mikrobiol Z; 2001; 63(4):53-61. PubMed ID: 11692678
[TBL] [Abstract][Full Text] [Related]
13. Complete genome sequence of Streptomyces peucetius ATCC 27952, the producer of anticancer anthracyclines and diverse secondary metabolites.
Dhakal D; Lim SK; Kim DH; Kim BG; Yamaguchi T; Sohng JK
J Biotechnol; 2018 Feb; 267():50-54. PubMed ID: 29307836
[TBL] [Abstract][Full Text] [Related]
14. Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement.
Malla S; Niraula NP; Liou K; Sohng JK
Microbiol Res; 2010 May; 165(4):259-67. PubMed ID: 19651502
[TBL] [Abstract][Full Text] [Related]
15. Genome analyses of Streptomyces peucetius ATCC 27952 for the identification and comparison of cytochrome P450 complement with other Streptomyces.
Parajuli N; Basnet DB; Chan Lee H; Sohng JK; Liou K
Arch Biochem Biophys; 2004 May; 425(2):233-41. PubMed ID: 15111132
[TBL] [Abstract][Full Text] [Related]
16. The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis.
Lomovskaya N; Doi-Katayama Y; Filippini S; Nastro C; Fonstein L; Gallo M; Colombo AL; Hutchinson CR
J Bacteriol; 1998 May; 180(9):2379-86. PubMed ID: 9573189
[TBL] [Abstract][Full Text] [Related]
17. A new peucemycin derivative and impacts of peuR and bldA on peucemycin biosynthesis in Streptomyces peucetius.
Magar RT; Pham VTT; Poudel PB; Bridget AF; Sohng JK
Appl Microbiol Biotechnol; 2024 Dec; 108(1):107. PubMed ID: 38217253
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of daunorubicin biosynthesis genes from Streptomyces peucetius and S. peucetius subsp. caesius.
Otten SL; Stutzman-Engwall KJ; Hutchinson CR
J Bacteriol; 1990 Jun; 172(6):3427-34. PubMed ID: 2345153
[TBL] [Abstract][Full Text] [Related]
19. Implication of orphan histidine kinase (OhkAsp) in biosynthesis of doxorubicin and daunorubicin in Streptomyces peucetius ATCC 27952.
Pokhrel AR; Nguyen HT; Dhakal D; Chaudhary AK; Sohng JK
Microbiol Res; 2018 Sep; 214():37-46. PubMed ID: 30031480
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of doxorubicin production in Streptomyces peucetius: a review.
Hutchinson CR; Colombo AL
J Ind Microbiol Biotechnol; 1999 Jul; 23(1):647-52. PubMed ID: 10455495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
